Annual report 2022

12 Goodwill and other intangible assets

 

 

2022

millions of CHF

 

Goodwill

 

Trademarks and licenses

 

Research and development

 

Computer software

 

Customer relationships

 

Total

Acquisition cost

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

258.0

 

78.5

 

6.0

 

17.8

 

231.8

 

592.2

Acquired through business combination

 

5.2

 

1.3

 

 

 

6.9

 

13.4

Deconsolidation of medmix Poland

 

 

–0.0

 

 

–0.1

 

 

–0.2

Additions

 

 

0.0

 

0.0

 

2.1

 

 

2.2

Disposals

 

 

 

 

–0.1

 

 

–0.1

Currency translation differences

 

–8.8

 

–0.4

 

–0.2

 

–0.7

 

–7.7

 

–17.8

Balance as of December 31

 

254.4

 

79.4

 

5.8

 

19.1

 

231.0

 

589.7

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization and impairment losses

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

 

66.6

 

4.5

 

14.1

 

113.0

 

198.3

Deconsolidation of medmix Poland

 

 

–0.0

 

 

–0.1

 

 

–0.1

Additions

 

 

2.6

 

0.4

 

1.3

 

16.5

 

20.8

Disposals

 

 

 

 

–0.1

 

 

–0.1

Impairments

 

 

 

 

 

 

Currency translation differences

 

 

–0.3

 

–0.2

 

–0.1

 

–3.5

 

–4.1

Balance as of December 31

 

 

69.0

 

4.7

 

15.1

 

126.0

 

214.8

 

 

 

 

 

 

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

 

 

 

As of January 1

 

258.0

 

11.9

 

1.5

 

3.7

 

118.8

 

393.9

As of December 31

 

254.4

 

10.4

 

1.2

 

3.9

 

104.9

 

374.9

 

 

2021

millions of CHF

 

Goodwill

 

Trademarks and licenses

 

Research and development

 

Computer software

 

Customer relationships

 

Total

Acquisition cost

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

265.4

 

78.6

 

5.6

 

15.7

 

237.4

 

602.7

Acquired through business combination

 

 

 

 

 

 

Additions

 

 

 

0.5

 

1.5

 

 

2.1

Disposals

 

 

 

–0.0

 

–0.1

 

 

–0.1

Currency translation differences

 

–7.4

 

–0.1

 

–0.2

 

0.7

 

–5.6

 

–12.5

Balance as of December 31

 

258.0

 

78.5

 

6.0

 

17.8

 

231.8

 

592.2

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated amortization and impairment losses

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of January 1

 

 

64.0

 

4.0

 

13.3

 

97.3

 

178.6

Additions

 

 

2.9

 

0.5

 

1.0

 

17.7

 

22.2

Disposals

 

 

 

–0.0

 

–0.1

 

 

–0.1

Impairments

 

 

 

0.1

 

 

 

0.1

Currency translation differences

 

 

–0.3

 

–0.2

 

–0.0

 

–2.1

 

–2.6

Balance as of December 31

 

 

66.6

 

4.5

 

14.1

 

113.0

 

198.3

 

 

 

 

 

 

 

 

 

 

 

 

 

Net book value

 

 

 

 

 

 

 

 

 

 

 

 

As of January 1

 

265.4

 

14.7

 

1.6

 

2.4

 

140.0

 

424.1

As of December 31

 

258.0

 

11.9

 

1.5

 

3.7

 

118.8

 

393.9

Goodwill impairment test

 

 

2022

millions of CHF

 

Goodwill

 

Headroom

 

Growth rate residual value

 

Pretax discount rate

Healthcare

 

69.9

 

1’604.3

 

2.0%

 

7.9%

Consumer & Industrial

 

184.5

 

375.8

 

2.0%

 

9.5%

Total as of December 31

 

254.4

 

1’980.1

 

 

 

 

 

 

2021

millions of CHF

 

Goodwill

 

Headroom

 

Growth rate residual value

 

Pretax discount rate

Healthcare

 

58.2

 

1’976.0

 

2.0%

 

5.6%

Consumer & Industrial

 

199.8

 

855.2

 

2.0%

 

5.6%

Total as of December 31

 

258.0

 

2’831.2

 

 

 

 

Goodwill is allocated to the smallest cash-generating unit at which goodwill is monitored for internal management purposes (i.e., business area). The recoverable amount of these units is determined over a five-year cash flow projection period.

The calculation is based on the budget for the first period (2022), the three-year strategic plan for the subsequent two periods (2023–2024) and a management calculation for the next two periods (2025–2026). The budget and the three-year strategic plan were approved by the Board of Directors in February 2022. Cash flows beyond the planning period are extrapolated using a terminal value including the growth rates as stated above.

As of December 31, 2022, there is no indication for goodwill impairment. Updating the impairment test would not have resulted in a goodwill impairment.

Sensitivity analyses

The recoverable amount from cash-generating units is measured on the basis of value-in-use calculations significantly impacted by the terminal growth rate used to determine the residual value, the discount rate and the projected cash flows. The table above shows the amount by which the estimated recoverable amount of the CGU exceeds its carrying amount (headroom).

Management determined there are no reasonably possible changes in key assumptions that would result in a goodwill impairment.